Get startedLog in
    Picture of BLS Pharmaceuticals logo

    BXNDA — BLS Pharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    All News

    Brief: Bioxyne Qtrly Group Revenue About A$2.1 MLN, Up 75%

    Picture of BLS Pharmaceuticals logoBLS Pharmaceuticals
    31/10/2023 07:29
    Oct 31 (Reuters) - Bioxyne Ltd  BXN.AX :
    * QTRLY GROUP REVENUE ABOUT A$2.1 MILLION, UP 75%

Source text for Eikon:  ID:nASX7fj0r 
Further company coverage:  BXN.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on BLS Pharmaceuticals

    See all news